Back
Marker Therapeutics Stock Price Chart
Multimillionaire Trader Reveals His #1 Gold Pick
Click here to learn more about this game-changing opportunity.
Sell
46
MRKR
Marker Therapeutics
Last Price:
3.35
Seasonality Move:
-1.19%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the Ultimate Gold Play: $20 for a 1 Oz Stake in Gold!
Don't miss out-click here for urgent details on the #1 gold play of the year!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRKR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Marker Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.93 | Buy |
| 20-day SMA: | 2.82 | Buy |
| 50-day SMA: | 3.12 | Buy |
| 200-day SMA: | 4.11 | Sell |
| 8-day EMA: | 3.06 | Buy |
| 20-day EMA: | 2.93 | Buy |
| 50-day EMA: | 3.21 | Buy |
| 200-day EMA: | 3.84 | Sell |
Marker Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 62.79 | Buy |
| Chaikin Money Flow: | 34790 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.57 - 3.05) | Buy |
| Bollinger Bands (100): | (2.93 - 4.81) | Sell |
Marker Therapeutics Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marker Therapeutics Stock
Is Marker Therapeutics Stock a Buy?
- Marker Therapeutics share price is 3.52 while MRKR 8-day simple moving average is 2.93, which is a Buy signal.
- The stock price of MRKR is 3.52 while Marker Therapeutics 20-day SMA is 2.82, which makes it a Buy.
- Marker Therapeutics 50-day simple moving average is 3.12 while MRKR share price is 3.52, making it a Buy technically.
- MRKR stock price is 3.52 and Marker Therapeutics 200-day simple moving average is 4.11, creating a Sell signal.
MRKR Technical Analysis vs Fundamental Analysis
Sell
46
Marker Therapeutics (MRKR)
is a Sell
Is Marker Therapeutics a Buy or a Sell?
-
Marker Therapeutics stock is rated a Sell
The current Marker Therapeutics [MRKR] share price is $3.52. The Score for MRKR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Marker Therapeutics Stock Info
Market Cap:
31.41M
Price in USD:
3.52
Share Volume:
53.78K
Marker Therapeutics 52-Week Range
52-Week High:
6.16
52-Week Low:
2.40
Sell
46
Marker Therapeutics (MRKR)
is a Sell
Marker Therapeutics Share Price Forecast
-
What is the Marker Therapeutics stock price today?
The Marker Therapeutics stock price is 3.52 USD today. -
Will MRKR stock go up or go down?
Marker Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Marker Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marker Therapeutics is overvalued.
Is Marker Therapeutics Stock a Buy?
- Marker Therapeutics share price is 3.52 while MRKR 8-day exponential moving average is 3.06, which is a Buy signal.
- The stock price of MRKR is 3.52 while Marker Therapeutics 20-day EMA is 2.93, which makes it a Buy.
- Marker Therapeutics 50-day exponential moving average is 3.21 while MRKR share price is 3.52, making it a Buy technically.
- MRKR stock price is 3.52 and Marker Therapeutics 200-day simple moving average is 3.84, creating a Sell signal.
Fundamental Analysis of Marker Therapeutics
Is Marker Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Marker Therapeutics
Should I short Marker Therapeutics stock?
- MRKR Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Marker Therapeutics is a Buy
- Marker Therapeutics Relative Strength Index (RSI) is 62.79, which suggest Marker Therapeutics is overbought
- The Bollinger Bands (25) for Marker Therapeutics is (2.57 - 3.05), which suggest Marker Therapeutics is a Sell
- The Bollinger Bands (100) for Marker Therapeutics is (2.93 - 4.81), which suggest Marker Therapeutics is a Sell
* Marker Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.